TRCT
NSPR icon

Tower Research Capital (TRC)’s InspireMD NSPR Stock Holding History

Tower Research Capital (TRC)’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-96
Closed – – 6349
2022
Q2 		$0 Buy
+96
New +$228 ﹤0.01% 6387
2022
Q1 		– Sell
-1
Closed – – 6419
2021
Q4 		$0 Buy
+1
New +$4 ﹤0.01% 6425
2015
Q3 		– Hold
0
– – – 4537
2015
Q2 		– Hold
0
– – – 4829
2015
Q1 		– Hold
0
– – – 4761
2014
Q4 		– Hold
0
– – – 4470
2014
Q3 		– Hold
0
– – – 4744
2014
Q2 		– Hold
0
– – – 4450
2014
Q1 		– Hold
0
– – – 4176
2013
Q4 		– Hold
0
– – – 4233

Other funds holding NSPR

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Avestar Capital New York $1.56B AUM 31.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BAM
Bellevue Asset Management Bellevue, Washington $200M AUM 16.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FP
Financial Perspectives Minneapolis, Minnesota $358M AUM 22.18% 1-Year Est. Return

Tower Research Capital (TRC)'s NSPR Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of InspireMD (NSPR) in Q3 2022, closing a stake of 96 shares.

Tower Research Capital (TRC) first reported a position in NSPR in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 16 funds tracked by Wall St. Rank hold NSPR as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining InspireMD position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 96 InspireMD shares in Q3 2022.
  • Tower Research Capital (TRC) first reported a position in InspireMD in Q4 2021 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s InspireMD position peaked at $0 in Q2 2022.
  • 16 funds tracked by Wall St. Rank held InspireMD as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.